Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials
Copyright © 2024 Elsevier Inc. All rights reserved..
OBJECTIVE: To gain consensus on the definitions and descriptions of the domains of the Outcome Measures in Rheumatology (OMERACT) core domain set for rheumatology trials evaluating shared decision making (SDM) interventions.
METHODS: Following the OMERACT Handbook methods, our Working Group (WG), comprised of 90 members, including 17 patient research partners (PRPs) and 73 clinicians and researchers, had six virtual meetings in addition to email exchanges to develop draft definitions and descriptions. The WG then conducted an international survey of its members to gain consensus on the definitions and descriptions. Finally, the WG members had virtual meetings and e-mail exchanges to review survey results and finalize names, definitions and descriptions of the domains.
RESULTS: WG members contributed to developing the definitions. Fifty-two members representing four continents and 13 countries completed the survey, including 15 PRPs, 33 clinicians and 37 researchers. PRPs and clinicians/researchers agreed with all definitions and descriptions with agreements ranging from 87% to 100%. Respondents suggested wording changes to the names, definitions and descriptions to better reflect the domains. Discussions led to further simplification and clarification to address common questions/concerns about the domains.
CONCLUSION: Our WG reached consensus on the definitions and descriptions of the domains of the core domain set for rheumatology trials of SDM interventions. This step is crucial to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set.
CLINICAL SIGNIFICANCE: The current study provides consensus-based definitions and descriptions for the domains of the OMERACT core domain set for shared decision making interventions from patients/caregivers, clinicians and researchers. This is a crucial step to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set for trials of SDM interventions.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
|---|---|
| Enthalten in: |
Seminars in arthritis and rheumatism - 65(2024) vom: 02. März, Seite 152381 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Consensus-building |
|---|
| Anmerkungen: |
Date Completed 22.03.2024 Date Revised 22.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.semarthrit.2024.152381 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367961954 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367961954 | ||
| 003 | DE-627 | ||
| 005 | 20240323000701.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240203s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.semarthrit.2024.152381 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1341.xml |
| 035 | |a (DE-627)NLM367961954 | ||
| 035 | |a (NLM)38306813 | ||
| 035 | |a (PII)S0049-0172(24)00022-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Décary, Simon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.03.2024 | ||
| 500 | |a Date Revised 22.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier Inc. All rights reserved. | ||
| 520 | |a OBJECTIVE: To gain consensus on the definitions and descriptions of the domains of the Outcome Measures in Rheumatology (OMERACT) core domain set for rheumatology trials evaluating shared decision making (SDM) interventions | ||
| 520 | |a METHODS: Following the OMERACT Handbook methods, our Working Group (WG), comprised of 90 members, including 17 patient research partners (PRPs) and 73 clinicians and researchers, had six virtual meetings in addition to email exchanges to develop draft definitions and descriptions. The WG then conducted an international survey of its members to gain consensus on the definitions and descriptions. Finally, the WG members had virtual meetings and e-mail exchanges to review survey results and finalize names, definitions and descriptions of the domains | ||
| 520 | |a RESULTS: WG members contributed to developing the definitions. Fifty-two members representing four continents and 13 countries completed the survey, including 15 PRPs, 33 clinicians and 37 researchers. PRPs and clinicians/researchers agreed with all definitions and descriptions with agreements ranging from 87% to 100%. Respondents suggested wording changes to the names, definitions and descriptions to better reflect the domains. Discussions led to further simplification and clarification to address common questions/concerns about the domains | ||
| 520 | |a CONCLUSION: Our WG reached consensus on the definitions and descriptions of the domains of the core domain set for rheumatology trials of SDM interventions. This step is crucial to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set | ||
| 520 | |a CLINICAL SIGNIFICANCE: The current study provides consensus-based definitions and descriptions for the domains of the OMERACT core domain set for shared decision making interventions from patients/caregivers, clinicians and researchers. This is a crucial step to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set for trials of SDM interventions | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Consensus-building | |
| 650 | 4 | |a Core domain set | |
| 650 | 4 | |a OMERACT | |
| 650 | 4 | |a Rheumatology | |
| 650 | 4 | |a Shared decision making | |
| 650 | 4 | |a Survey | |
| 700 | 1 | |a de Wit, Maarten |e verfasserin |4 aut | |
| 700 | 1 | |a Naye, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Barton, Jennifer L |e verfasserin |4 aut | |
| 700 | 1 | |a Fraenkel, Liana |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Linda C |e verfasserin |4 aut | |
| 700 | 1 | |a Brooks, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Stacey, Dawn |e verfasserin |4 aut | |
| 700 | 1 | |a Maxwell, Lara J |e verfasserin |4 aut | |
| 700 | 1 | |a Campbell, Willemina |e verfasserin |4 aut | |
| 700 | 1 | |a Hofstetter, Cathie |e verfasserin |4 aut | |
| 700 | 1 | |a Voshaar, Marieke |e verfasserin |4 aut | |
| 700 | 1 | |a Meara, Alexa |e verfasserin |4 aut | |
| 700 | 1 | |a Christensen, Robin |e verfasserin |4 aut | |
| 700 | 1 | |a Boonen, Annelies |e verfasserin |4 aut | |
| 700 | 1 | |a Suarez-Almazor, Maria E |e verfasserin |4 aut | |
| 700 | 1 | |a Meade, Tanya |e verfasserin |4 aut | |
| 700 | 1 | |a March, Lyn |e verfasserin |4 aut | |
| 700 | 1 | |a Jull, Janet Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Alten, Rieke |e verfasserin |4 aut | |
| 700 | 1 | |a Morgan, Esi M |e verfasserin |4 aut | |
| 700 | 1 | |a Stewart Hazlewood, Glen |e verfasserin |4 aut | |
| 700 | 1 | |a Barber, Claire E H |e verfasserin |4 aut | |
| 700 | 1 | |a Guillemin, Francis |e verfasserin |4 aut | |
| 700 | 1 | |a El-Miedany, Yasser |e verfasserin |4 aut | |
| 700 | 1 | |a Mittoo, Shikha |e verfasserin |4 aut | |
| 700 | 1 | |a Robertson, Tiffany Westrich |e verfasserin |4 aut | |
| 700 | 1 | |a Bartlett, Susan J |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Jasvinder A |e verfasserin |4 aut | |
| 700 | 1 | |a Mannion, Melissa |e verfasserin |4 aut | |
| 700 | 1 | |a Nasef, Samah Ismail |e verfasserin |4 aut | |
| 700 | 1 | |a Boel, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Adebajo, Adewale |e verfasserin |4 aut | |
| 700 | 1 | |a Arnaud, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Gill, Tiffany K |e verfasserin |4 aut | |
| 700 | 1 | |a Moholt, Ellen |e verfasserin |4 aut | |
| 700 | 1 | |a Burt, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Jayatilleke, Arundathi |e verfasserin |4 aut | |
| 700 | 1 | |a Hmamouchi, Ihsane |e verfasserin |4 aut | |
| 700 | 1 | |a Berthelsen, Dorthe B |e verfasserin |4 aut | |
| 700 | 1 | |a Blanco, Francisco J |e verfasserin |4 aut | |
| 700 | 1 | |a Mather, Kate |e verfasserin |4 aut | |
| 700 | 1 | |a Maharaj, Ajesh |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Saurab |e verfasserin |4 aut | |
| 700 | 1 | |a Caso, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Beaton, Dorcas |e verfasserin |4 aut | |
| 700 | 1 | |a Shea, Beverly |e verfasserin |4 aut | |
| 700 | 1 | |a Fong, Christopher |e verfasserin |4 aut | |
| 700 | 1 | |a Fernandez, Anthony P |e verfasserin |4 aut | |
| 700 | 1 | |a Mackie, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Nikiphorou, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, Allyson |e verfasserin |4 aut | |
| 700 | 1 | |a Greer-Smith, Regina |e verfasserin |4 aut | |
| 700 | 1 | |a Sloan, Victor S |e verfasserin |4 aut | |
| 700 | 1 | |a Akpabio, Akpabio |e verfasserin |4 aut | |
| 700 | 1 | |a Strand, Vibeke |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Rebecca R |e verfasserin |4 aut | |
| 700 | 1 | |a Umaefulam, Valerie |e verfasserin |4 aut | |
| 700 | 1 | |a Monti, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Abaza, Nouran |e verfasserin |4 aut | |
| 700 | 1 | |a Schultz, Grayson |e verfasserin |4 aut | |
| 700 | 1 | |a Stones, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Gossec, Laure |e verfasserin |4 aut | |
| 700 | 1 | |a Nielsen, Sabrina Mai |e verfasserin |4 aut | |
| 700 | 1 | |a Cavallo, Sabrina |e verfasserin |4 aut | |
| 700 | 1 | |a Srinivasalu, Hemalatha |e verfasserin |4 aut | |
| 700 | 1 | |a Constien, Deb |e verfasserin |4 aut | |
| 700 | 1 | |a Evans, Vicki |e verfasserin |4 aut | |
| 700 | 1 | |a Tugwell, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Toupin-April, Karine |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Seminars in arthritis and rheumatism |d 1971 |g 65(2024) vom: 02. März, Seite 152381 |w (DE-627)NLM000215643 |x 1532-866X |7 nnns |
| 773 | 1 | 8 | |g volume:65 |g year:2024 |g day:02 |g month:03 |g pages:152381 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.semarthrit.2024.152381 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 65 |j 2024 |b 02 |c 03 |h 152381 | ||